"Designing Growth Strategies is in our DNA"

Veterinary Drugs Market Size, Share and Industry Analysis by Product (Anti-infectives, Anti-inflammatory, Parasiticides, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral,Topical), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others,) and Regional Forecast, 2018 - 2025

Region : Global | Format: PDF | Report ID: FBI100171

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version
COVID-19 Cover

We are in process of revamping Veterinary Drugs Market with respect to COVID-19 Impact.

Inquire before buying

Existing market players operating in the global veterinary drugs Industry are focusing on constant innovation and upgrading their portfolio with new and advanced product offerings for both the livestock and the companion animals. Some of the key driving factors of the global market include the rapid population growth, rising per capita income, and increased urbanization.


These factors have led to the development of the key important trends of increased demand for animals and animal-derived products and the increased companion animal ownership leading to greater expenditure of veterinary drugs to enable longer and healthier lives of these animals.


The introduction of new and advanced veterinary drugs is expected to drive the global veterinary drugs market growth in developed as well as emerging countries, subsequently driving the growth in the market during the forecast period 2018-2025. In May 2019, the U.S. FDA granted regulatory approval to Bimeda, Inc. for the product offering of OxyMed LA treatment of pneumonia and shipping fever complex in cattle and the treatment of bacterial enteritis. 


Request a sample to learn more about this report.


"Increasing animal ownership and the launch of new veterinary drugs products for a variety of indications and types of animals is driving the growth of the global market "


Increased animal ownership and the increased demand for animal-derived products were some of the most prominent driving factors for the growth in the market in 2017. Parasiticides segment is estimated to have the largest share among application types. Parasiticides accounted for a veterinary drugs market share of 32.2% in 2017. While, the positive effects of parasiticides cannot be generally seen but if the animals are not treated against parasites or prevented against parasites they tend to have a devastating impact on the animals and hence, parasiticides was estimated as most preferred veterinary drugs.


Globally, parasiticides product segment is estimated to grow at a faster CAGR in the market during the forecast period. This is attributed to increasing demand for animals and animal-derived products such as meat, and the administration of parasiticides enable to boosting the quality of the meat for consumption and improve the overall efficiency of the livestock and companion animals.


Currently, there are increasing technological advancements in the administration of parasiticides such as collars, dips, and sprays and this is expected to boost the veterinary drugs market growth at a significantly high CAGR during the forecast period.


To know how our report can help streamline your business, Speak to Analyst


Based on the animal type, the market segments include companion and livestock. Based on the product, the veterinary drugs market segments include parasiticides, anti-infectives, anti-inflammatory, and others. The parasiticides segment dominated the global market in 2017. The segment accounted for 32.2% share of the market in 2017. Based on route of administration, the global market is categorized into oral, parenteral, and topical. In terms of distribution channels, the global market is categorized into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others.


REGIONAL ANALYSIS


"Growing animal ownership and increasing usage of veterinary drugs expected to result in the highest CAGR in the Asia Pacific"


North America generated veterinary drugs market revenue of USD 6,290.1 Mn in 2017 and is anticipated to account for a major share in the market during the forecast period. Growth projected in the region is likely to be driven by increasing adoption of animals, and advanced and improved new product launches in the region. In developed countries the use of veterinary drugs is continuously increasing due to high animal ownership and stringent animal healthcare guidelines along with the R&D initiatives leading to launching of new products, which may also be attributed to the increasing demand for animals.


In Europe, the veterinary drugs market growth will continue due to the stringent guidelines regarding animal health. In Asia Pacific, emerging countries such as India and China, the increasing consumption of advanced veterinary drugs will fuel the growth in the market during the forecast period. In Asian countries like China and India, there is increased animal health awareness due to government initiatives, increased usage of animals in agriculture in some regions and increasing disposable incomes leading to greater veterinary drugs expenditure.


The adoption of other veterinary drugs such as anti-infectives and anti-inflammatory is also increasing. In Latin America, the market is anticipated to strengthen due to the beef consumption industry in some of the countries in the region. Middle East & Africa also continues to represent strong growth potential in the future.


North America Veterinary Drugs Market, 2017

To get more information on the regional analysis of this market, Request a sample


KEY MARKET PLAYERS


"Zoetis, Boehringer Ingelheim and Intervet, dominated the global veterinary drugs market in 2017" 


Zoetis emerged as the leading player with the highest veterinary drugs market share in 2017, as the company has a significant and considerable market presence, a diverse portfolio of product offerings and an acute strategic perspective which includes mergers and acquisitions such as the 2018 acquisition of Abaxis.


Other examples of strategic acquisitions of the company include Nexvet and Scandinavian Micro Biodevices. In addition, Zoetis is continuously involved in a variety of R&D initiatives such as animal cancer therapeutics. Other players operating in the Industry are Intervet Inc., Boehringer Ingelheim International GmbH, Ceva, Elanco, Vetoquinol S.A., Bayer AG, etc. 


List of Companies Profiled



REPORT COVERAGE


The global veterinary drugs market is anticipated to grow owing to a number of factors such as the increasing prevalence of animal diseases, increasing incidences of zoonotic diseases, increase in pet ownership, increased demand for meat and animal-based products, usage of animals in agriculture, easy accessibility and affordability of treatment, increasing awareness of animal health and welfare, and increasing animal adoption. The introduction of new products in the market, along with an increasing number of animals worldwide undergoing therapeutic treatments is projected to further augment the demand for veterinary drugs during the forecast period. 


The report provides qualitative and quantitative insights on the veterinary drugs industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The market segments include product, animal, route of administration, distribution channel, and geography. On the basis of the product, the global market segments include anti-infectives, anti-inflammatory, parasiticides, and others.


Based on animal, the global market is segmented into companion, and livestock. Based on route of administration, the global market for veterinary drugs market is segmented into oral, parenteral, and topical. Based on distribution channel, the global market is segmented into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further categorized into countries. 


To gain extensive insights into the market, Request for Customization


Along with this, the report on veterinary drugs market analysis includes market dynamics and competitive landscape. Various key insights provided in the report are the pipeline analysis of veterinary drugs, overview of company share analysis, overview of strategies by key market leaders, key industry developments such as mergers & acquisitions, new product launches, regulatory Scenario, and overview of cost analysis.


SEGMENTATION






























 ATTRIBUTE



 DETAILS



By Product



· Anti-infectives


· Anti-inflammatory


· Parasiticides


· Others



By Animal



· Companion


· Livestock



By Route of Administration



· Oral


· Parenteral


· Topical



Distribution Channel



· Veterinary Hospitals


· Veterinary Clinics


· Pharmacies & Drug Stores


· Others



By Geography



· North America (U.S. and Canada)


· Europe (U.K., Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


KEY INDUSTRY DEVELOPMENTS



  • In May 2019, the U.S. FDA granted regulatory approval to Bimeda, Inc. for the product offering of OxyMed LA treatment of pneumonia and shipping fever complex in cattle and the treatment of bacterial enteritis

  • In May 2019, the U.S. FDA granted regulatory approval to Bimeda, Inc., for the product offering of EnroMed 100 for the treatment of bovine respiratory disease (BRD) in bovine and swine respiratory disease (SRD) in swine

  • In May 2019, Pharmgate Inc. received the regulatory approval from the U.S. FDA for the control of swine dysentery, for the product offering of Denagard and Deracin


Frequently Asked Questions

Fortune Business Insights says that the Veterinary Drugs Market was valued at US$ 17.87 Bn in 2018 and is projected to reach US$ 27.57 Bn by 2026.

In 2018, the Veterinary Drugs Market was valued at US$ 17.87 Bn.

Growing at a CAGR of 5.6 %, the Veterinary Drugs Market will exhibit steady growth in the forecast period (2019-2026)

Parasiticides Veterinary Drugs segment is expected to be the leading segment in Veterinary Drugs Market during the forecast period.

Increasing animal ownership and the launch of new veterinary drugs products for a variety of indications and types of animals are some of the factors anticipated to drive the growth of the Veterinary Drugs Market.

Zoetis, Boehringer Ingelheim and Intervet are the top players in Veterinary Drugs Market.

North America is expected to hold the highest market share in the Veterinary Drugs Market.

Growing animal ownership and increasing usage of veterinary drugs are some of the market trends of Veterinary Drugs.

Veterinary Drugs Market Size, Share and Global Industry Trend Forecast till 2026
  • Apr, 2019
  • 2017
  • 2014-2016
  • 158

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X